Live from the NIH registry
Studies recruiting near Norfolk right now
Top 25 of 401 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Cancer Specialists of Tidewater Limited — Chesapeake, Virginia (5.3 mi)
· Sponsor: SWOG Cancer Research Network
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Norfolk, Virginia (3.6 mi)
· Sponsor: Sameek Roychowdhury
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
Virginia Oncology Associates (VOA) ( Site 8008) — Norfolk, Virginia (3.6 mi)
· Sponsor: Merck Sharp & Dohme LLC
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Norfolk, Virginia (3.6 mi)
· Sponsor: Daiichi Sankyo
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Gastroenterology Associates of Tidewater — Chesapeake, Virginia (5.3 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
Children's Hospital of The King's Daughters — Norfolk, Virginia (3.6 mi)
· Sponsor: Children's Oncology Group
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Norfolk, Virginia (3.6 mi)
· Sponsor: AstraZeneca
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Virginia Beach, Virginia (15.8 mi)
· Sponsor: TG Therapeutics, Inc.
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Virginia Oncology Associates — Norfolk, Virginia (3.6 mi)
· Sponsor: SCRI Development Innovations, LLC
Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps
Chronic Rhinosinusitis Without Nasal Polyps
Phase 3
Interventional 84 participants sought
EVMS at Old Dominion University — Norfolk, Virginia (3.6 mi)
· Sponsor: Optinose US Inc.
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
RSV Infection
Phase 3
Interventional 550 participants sought
Sentara Leigh Hospital — Norfolk, Virginia (3.6 mi)
· Sponsor: Pfizer
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
TPMG Clinical Research — Newport News, Virginia (11.1 mi)
· Sponsor: Duke University
Oxytocin/Foley vs. Oxytocin for Induction in Patients With PPROM
Preterm PROM (Pregnancy)
Phase 4
Interventional 80 participants sought
Sentara Norfolk General Hospital — Norfolk, Virginia (3.6 mi)
· Sponsor: Eastern Virginia Medical School
Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age
Lymphatic Malformation
Phase 2
Interventional 38 participants sought
Children's Hospital of the King's Daughters — Norfolk, Virginia (3.6 mi)
· Sponsor: Protara Therapeutics
Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 2
Interventional 300 participants sought
AMR Norfolk — Norfolk, Virginia (3.6 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Heart Failure
Phase 2
Interventional 200 participants sought
Sentara Bayside Hospital — Norfolk, Virginia (3.6 mi)
· Sponsor: Novo Nordisk A/S
Cast Art for Kids With Extremity Fractures
Fractures, Bone
N/A
Interventional 96 participants sought
Naval Medical Center Portsmouth — Portsmouth, Virginia (4.6 mi)
· Sponsor: United States Naval Medical Center, Portsmouth
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Obesity, Knee Osteoarthritis (OA)
Phase 3
Interventional 400 participants sought
Health Res of Hampton Roads — Newport News, Virginia (11.1 mi)
· Sponsor: Novo Nordisk A/S
Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure
Healthy Adult Participants
N/A
Observational 15 participants sought
Decentralized / At-Home Participation (U.S.) — Virginia Beach, Virginia (15.8 mi)
· Sponsor: Ecotera Health LLC
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
Peripheral Arterial Disease, Atherosclerosis of Extremities
Phase 3
Interventional 6,150 participants sought
Sentara Norfolk General Hospital — Norfolk, Virginia (3.6 mi)
· Sponsor: Population Health Research Institute
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
Breast Cancer
Phase 2
Interventional 36 participants sought
Virginia Oncology Associates — Norfolk, Virginia (3.6 mi)
· Sponsor: SCRI Development Innovations, LLC
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Norfolk, VA Investigative Site 10009 — Norfolk, Virginia (3.6 mi)
· Sponsor: Colorado Prevention Center
Effect of Fiber Supplementation on the Need for Medication With Gestational Diabetes
Gestational Diabetes Mellitus (GDM)
N/A
Interventional 110 participants sought
Macon & Joan Brock Virginia Health Sciences at ODU — Norfolk, Virginia (3.6 mi)
· Sponsor: Eastern Virginia Medical School
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Transthyretin Amyloidosis With Cardiomyopathy
Phase 3
Interventional 1,750 participants sought
Clinical Trial Site — Norfolk, Virginia (3.6 mi)
· Sponsor: Alnylam Pharmaceuticals
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Velocity Clinical Research, Suffolk — Suffolk, Virginia (21.4 mi)
· Sponsor: Sparrow Pharmaceuticals